Hereditary breast and/or ovarian cancer syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

Regulatory Watchboard

No FDA or trial events recorded yet for Hereditary breast and/or ovarian cancer syndrome.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Hereditary breast and/or ovarian cancer syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Avmapki Fakzynja Co-Pack

(avutometinib; defactinib)Orphan drug

Verastem, Inc.

12.1 Mechanism of Action Avutometinib Avutometinib is a MEK1 inhibitor. Avutometinib induces the formation of inactive RAF/MEK complexes and prevents ...

Approved May 2025FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary breast and/or ovarian cancer syndrome.
Search all trials →

Search clinical trials for Hereditary breast and/or ovarian cancer syndrome →

Recent News & Research

No recent news articles indexed yet for Hereditary breast and/or ovarian cancer syndrome.
Search PubMed for Hereditary breast and/or ovarian cancer syndrome →

Browse all Hereditary breast and/or ovarian cancer syndrome news →

Specialist Network

No specialists currently listed for Hereditary breast and/or ovarian cancer syndrome.

View all Hereditary breast and/or ovarian cancer syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰